PHALANX BIOTECH
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
Maternal and Child Health Testing: Provides prenatal and postnatal chromosomal microarray screening, such as CytoOneArray, which can screen for more than 400 genetic disorders in a single test, including chromosomal abnormalities and developmental delays.
Precision Oncology: Develops breakthrough ctDNA methylation technology for early liver cancer screening, while also providing pharmacogenomic testing services for cancers such as breast cancer, colorectal cancer, and lung cancer.
Gynecologic Cancer Screening: Offers services such as the AmpliGene Test, enabling simultaneous screening for endometrial cancer and cervical cancer.
Research and Contract Manufacturing: Possesses high-density gene chip R&D and manufacturing capabilities, and provides customized gene chip design and processing services on an ODM/OEM basis.
Precision Oncology: Develops breakthrough ctDNA methylation technology for early liver cancer screening, while also providing pharmacogenomic testing services for cancers such as breast cancer, colorectal cancer, and lung cancer.
Gynecologic Cancer Screening: Offers services such as the AmpliGene Test, enabling simultaneous screening for endometrial cancer and cervical cancer.
Research and Contract Manufacturing: Possesses high-density gene chip R&D and manufacturing capabilities, and provides customized gene chip design and processing services on an ODM/OEM basis.
The content above was translated by Ai
Founded Year
2025
Unified Business No.
60763646
Status
Active
Total Paid-in
Capital
170,000,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
PHALANX BIOTECH specializes in developing genetic testing platforms, utilizing technologies like microarray chips, next-generation sequencing, and big data analysis.
The content above was translated by Ai
